Abstract
INTRODUCTION:Lewy body dementia is a highly prevalent neurodegenerative disease and often goes unnoticed due to little knowledge about it. In dementias there may be gait alterations that potentially allow the identification of its subtype and provide early clinical, diagnostic, and therapeutic guidance. This narrative review of the literature aims to review gait changes that have been described as associated with Lewy body dementia.
MATERIALS AND METHODS:A literature review was carried out on the relationship of gait disturbances and LBD. The following search parameters were selected using the Scopus search engine: ((falls and dementia and gait and (evaluation or analysis))). The data were ordered according to relevance, obtaining 267 results. Likewise, a search was made in PubMed, using the terms (gait and lewy-body-disease), and no other filters were used, obtaining 139 results. A non-systematic selection of literature was made to carry out a narrative review about the changes in gait associated with LBD.
RESULTS:We found that gait disturbances may have an important predictive value in LBD. Patients with dementias not due to AD or vascular causes have a faster deterioration of physical function compared to patients with AD and without cognitive problems. The incorrect prioritization of tasks evidenced in PD is also observable in patients with LBD and is associated with the "dual-task" paradigm in patients with major neurocognitive disorder. Freezing of gait, also known as motor block or "freezing of gait" has been associated with a greater progression of cognitive impairment. Patients with LBD also show greater compromise in swing time, stride duration variability, poorer performance in gait pace and variability, and gait instability with inappropriate postures.
CONCLUSIONS:We observe that there is a relationship between LBD and falls in the elderly. Changes in gait and performance tests could have clinical utility as factors associated with LBD as well as falls in the elderly. There appears to be a characteristic variation between gait parameters and dementia subtypes that may have value as a diagnostic marker. More studies are required on this subject since there is little evidence available to date, which makes it impossible to define with greater precision the most sensitive alterations in each domain of gait that make it possible to differentiate normal from pathological aging.
References
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies. Neurology. 2017;89(1):88-100. https://n.neurology.org/content/89/1/88.
Vann Jones SA, O'Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44(4):673-83. https://www.cambridge.org/core/journals/psychological-medicine/article/abs/prevalence-and-incidence-of-dementia-with-lewy-bodies-a-systematic-review-of-population-and-clinical-studies/ AACD0AA4F8BC4CB1EA8A1C7E4F6660CD
Borda MG, Aarsland D, Tovar-Rios DA, Giil LM, Ballard C, Gonzalez MC, et al. Neuropsychiatric symptoms and functional decline in Alzheimer's disease and Lewy body dementia. J Am Geriatr Soc. 2020;68(10):2257-63. https://onlinelibrary.wiley.com/doi/full/10.1111/jgs.16709
AUali G, Verghese J. Management of gait changes and fall risk in MCI and dementia. Curr Treat Options Neurol. 2017;19(9):1-18. https://link.springer.com/article/10.1007/s11940-017-0466-1
Montero-Odasso M, Pieruccini-Faria F, Ismail Z, Li K, Lim A, Phillips N, et al. CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus. Alzheimer's Dement Transl Res Clin Interv 2020;6(1):e12068. https://onlinelibrary.wiley.com/doi/full/10.1002/trc2.12068
Hausdorff JM. Gait dynamics, fractals and falls: Finding meaning in the stride-to-stride fluctuations of human walking. Hum Mov Sci. 2007;26(4):555-89.
McArdle R Morris R, Wilson J, Galna B, Thomas AJ, Rochester L. What can quantitative gait analysis tell us about dementia and its subtypes? A structured review. J Alzheimer's Dis. 2017;60(4):1295-312.
Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ, Buschke H. Abnormality of gait as a predictor of Non-Alzheimer's dementia. N Engl J Med. 2002;347(22):1761-8. https://doi.org/10.1056/NEJMoa020441
Fritz NE, Kegelmeyer DA, Kloos AD, Linder S, Park A, Kataki M, et al. Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease. Gait Posture. 2016;50:1-7.
Merory JR, Wittwer JE, Rowe CC, Webster KE. Quantitative gait analysis in patients with dementia with Lewy bodies and Alzheimer's disease. Gait Posture. 2007;26(3):414-9.
Tanaka A, Okuzumi H, Kobayashi I, Murai N, Meguro K, Nakamura T. Gait disturbance of patients with vascular and Alzheimer-type dementias. Percept Mot Skills. 1995;80(3 Pt 1):735-8. https://journals.sagepub.com/doi/10.2466/pms.1995.80.3.735
Beauchet O, Annweiler C, Callisaya ML, De Cock AM, Helbostad JL, Kressig RW et al. Poor gait performance and prediction of dementia: results from a meta-analysis. J Am Med Dir Assoc. 2016;17(6):482-90. http://www.jamda.com/article/S1525861015008518/fulltext
Anand Ravindranath P, Raman R, Chow TW, Rafii MS, Aisen PS, Jimenez-Maggiora G. TD-P-015: continuous monitoring of gait: what can it tell us about dementia? Alzheimer's Dement. 2018;14(7S_Part_3):P192-3. https://onlinelibrary.wiley.com/doi/full/10.1016/j.jalz.2018.06.2031
Amboni M, Barone P, Hausdorff JM. Cognitive contributions to gait and falls: Evidence and implications. Mov Disord. 2013;28(11):1520-33. https://onlinelibrary.wiley.com/doi/fuU/10.1002/mds.25674
Taylor ME, Ketels MM, Delbaere K, Lord SR, Mikolaizak AS, Close JCT. Gait impairment and falls in cognitively impaired older adults: an explanatory model of sensorimotor and neuropsychological mediators. Age Ageing. 2012;41 (5):665-9. https://academic.oup.com/ageing/article/41/5/665/46996
Van Iersel MB, Hoefsloot W, Munneke M, Bloem BR, Olde Rikkert MGM. Systematic review of quantitative clinical gait analysis in patients with dementia. Z Gerontol Geriatr. 2004;37(1):27-32. https://link.springer.com/article/10.1007/s00391-004-0176-7
Podsiadlo D, Richardson S. The timed "up & go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142-8. https://onlinelibrary.wiley.com/doi/fuU/10.1111/j.1532-5415.1991.tb01616.x
Berg KO, Wood-Dauphinee SL, Williams JI, Maki B. Measuring balance in the elderly: validation of an instrument. Can J Public Health. 1992;83 (Suppl. 2):S7-11. https://europepmc.org/article/med/1468055
Hyndman D, Ashburn A. "Stops walking when talking" as a predictor of falls in people with stroke living in the community. J Neurol Neurosurg Psychiatry. 2004;75(7):994-7. https://jnnp.bmj.com/content/75/7/994
Zaccai J, McCracken C, Brayne C. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing. 2005;34(6):561-6. https://academic.oup.com/ageing/article/34/6/561/40401
Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies - UpToDate. https://www.uptodate.com/con-tents/epidemiology-pathology-and-pathogenesis-of-dementia-with-lewy-bodies
Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, et al. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol. 2010;257(3):359-66. https:// link.springer.com/article/10.1007/s00415-009-5324-y
Golimstok A. Risk factors for dementia with Lewy bodies: A case-control study. Neurology. 2014;82(15):1384-5. https://n.neurology.org/content/82/15/1384.2
Saito Y, Ruberu NN, Sawabe M, Arai T, Kazama H, Hosoi T, et al. Lewy body-related a-synucleinopathy in aging. J Neuro-pathol Exp Neurol. 2004;63(7):742-9. https://academic.oup.com/jnen/article/63/7/742/2916605
Woodruff BK, Graff-Radford NR, Ferman TJ, Dickson DW Delucia MW, Crook JE, et al. Family history of dementia is a risk factor for Lewy body disease. Neurology. 2006;66(12):1949-50. https://n.neurology.org/content/66/12/1949
Mrak RE, Sue W, Griffin T. Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer's disease. Neuropsychiatr Dis Treat. 2007;3(5):619.
Yamane Y, Sakai K, Maeda K. Dementia with Lewy bodies is associated with higher scores on the geriatric depression scale than is Alzheimer's disease. psychogeriatrics. 2011;11(3):157-65. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1479-8301.2011.00368.x
Cheng CK, Tsao YC, Su YC, Sung FC, Tai HC, Kung WM. Metabolic risk factors of Alzheimer's disease, dementia with Lewy bodies, and normal elderly: A population-based study. Behav Neurol. 2018;2018:8312346.
Hyun CH, Yoon CY, Lee H-J, Lee S-J. LRRK2 as a potential genetic modifier of synucleinopathies: interlacing the two major genetic factors of Parkinson's Disease. Exp Neurobiol. 2013;22(4):249-57. https://www.en-journal.org/journal/view.html?uid=196
Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, et al. A Multicenter study of glucocerebrosi-dase mutations in dementia with Lewy bodies. JAMA Neurol. 2013;70(6):727-35. https://jamanetwork.com/journals/jama-neurology/fullarticle/1678590
Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, et al. Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet. 2014;23(23):6139-46. https://academic.oup.com/hmg/article/23/23/6139/2900703
Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 2012;79(19):1944-50. https://n.neurology.org/content/79/19/1944
Borroni B, Grassi M, Costanzi C, Archetti S, Caimi L, Padovani A. APOE genotype and cholesterol levels in Lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk. Am J Geriatr Psychiatry. 2006;14(12):1022-31. http://www.ajgponline.org/article/S1064748112608896/fulltext
Seto-Salvia N, Pagonabarraga J, Houlden H, Pascual-Sedano B, Dols-Icardo O, Tucci A, et al. Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course. Mov Disord. 2012;27(3):393-9. https://onlinelibrary.wiley.com/doi/full/10.1002/mds.24045
Mata IF, Samii A, Schneer SH, Roberts JW, Griffith A, Leis BC, et al. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol. 2008;65(3):379-82. https://jamanetwork.com/journals/jamaneurology/fullar-ticle/795299
Goker-Alpan O, Giasson BI, Eblan MJ, Nguyen J, Hurtig HI, Lee VMY, et al. Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology. 2006;67(5):908-10. https://n.neurology.org/content/67/5/908
Berge G, Sando SB, Rongve A, Aarsland D, White LR. Apo-lipoprotein E s2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort. J Neurol Neurosurg Psychiatry. 2014;85(11):1227-31. https://jnnp.bmj.com/content/85/11/1227
Li T, Xie Y, Bowe B, Xian H, Al-Aly Z. Serum phosphorus levels and risk of incident dementia. PLoS One. 2017;12(2):e0171377. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171377
Elahi FM, Miller BL. A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 2017;13(8):457-76. https://www.nature.com/articles/nrneurol.2017.96
Janvin CC, Larsen JP, Salmon DP, Galasko D, Hugdahl K, Aarsland D. Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with Lewy bodies and Alzheimer's disease. Mov Disord. 2006;21(3):337-42. https://onlinelibrary.wiley.com/doi/fuU/10.1002/mds.20726
Park KW Kim HS, Cheon SM, Cha JK, Kim SH, Kim JW Dementia with Lewy bodies versus Alzheimer's disease and Parkinson's disease dementia: a comparison of cognitive profiles. J Clin Neurol. 2011;7(1):19-24. https://doi.org/10.3988/jcn.2011.7.1.19
Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor JP, Thomas AJ, et al. Clinical prevalence of Lewy body dementia. Alzheimer's Res Ther. 2018;10(1):1-8. https://alzres.biomedcentral.com/articles/10.1186/s13195-018-0350-6
Clinical features and diagnosis of dementia with Lewy bodies - UpToDate. https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-dementia-with-lewy-bodies
Menz HB, Lord SR, Fitzpatrick RC. Age-related differences in walking stability. Age Ageing. 2003;32(2):137-42. https://academic.oup.com/ageing/article/32/2/137/28914
Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ. Will my patient fall? JAMA. 2007;297(1):77-86. https://jamanetwork.com/journals/jama/fullarticle/204916
Ballard CG, Shaw F, Lowery K, McKeith I, Kenny R. The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord. 1999;10(2):97-103. https://www.karger.com/Article/FullText/17108
Imamura T, Hirono N, Hashimoto M, Kazui H, Tanimu-kai S, Hanihara T, et al. Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's disease. Eur J Neurol. 2000;7(1):77-9. https://onlinelibrary.wiley.com/doi/full/10.1046/j.1468-1331.2000.00021.x
Werner P, Savva GM, Maidment I, Thyrian JR, Fox C. Dementia: introduction, epidemiology and economic impact. Ment Heal Older People. 2016;197-209. https://link.springer.com/chapter/10.1007/978-3-319-29492-6_16
Montero-Odasso M, Verghese J, Beauchet O, Hausdorff JM. Gait and cognition: a complementary approach to understanding brain function and the risk of falling. J Am Geriatr Soc. 2012;60(11):2127-36. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1532-5415.2012.04209.x
Kantarci K, Ferman TJ, Boeve BF, Weigand SD, Przybelski S, Vemuri P, et al. Focal atrophy on MRI and neuro-pathologic classification of dementia with Lewy bodies. Neurology. 2012;79(6):553-60. https://n.neurology.org/content/79/6/553
Cousins DA, Burton EJ, Burn D, Gholkar A, McKeith IG, O'Brien JT. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease. Neurology. 2003;61(9):1191-5. https://n.neurology.org/content/61/9/1191
Soumaré A, Elbaz A, Zhu Y, Maillard P, Crivello F, Tavernier B, et al. White matter lesions volume and motor performances in the elderly. Ann Neurol. 2009;65(6):706-15. https://onlineli-brary.wiley.com/doi/full/10.1002/ana.21674
Blahak C, Baezner H, Pantoni L, Poggesi A, Chabriat H, Erkinjuntti T, et al. Deep frontal and periventricular age related white matter changes but not basal ganglia and infratento-rial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry. 2009;80(6):608-13. https://jnnp.bmj.eom/content/80/6/608
Herman T, Mirelman A, Giladi N, Schweiger A, Hausdorff JM. Executive control deficits as a prodrome to falls in healthy older adults: a prospective study linking thinking, walking, and falling. Journals Gerontol Ser A. 2010;65A(10):1086-92. https://academic.oup.com/biomedgerontology/article/65A/10/1086/572368
Muir SW, Gopaul K, Montero Odasso MM. The role of cognitive impairment in fall risk among older adults: a systematic review and meta-analysis. Age Ageing. 2012;41(3):299-308. https://academic.oup.com/ageing/article/41/3/299/32006
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.